1.
HuMax-CD38, a new human CD38 monoclonal antibody, effectively mediates killing of multiple myeloma and plasma cell leukemia cells. Hematol Meeting Rep [Internet]. 2009 Jun. 23 [cited 2025 Jul. 12];2(5). Available from:
https://journals.pagepress.org/hmr/article/view/740